Therapeutics

SAN DIEGO, Jan 28, 2023 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) common stock on the open market, or pursuant to Registration Statements…

SAN DIEGO, Jan 28, 2023 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Fate Therapeutics, Inc. (NASDAQ: FATE) securities between April 2, 2020 other January 5, 2023both dates inclusive (the…

NEW ORLEANS, Jan 27, 2023 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until March 20, 2023 to file lead plaintiff applications in a securities class action lawsuit against Y-mAbs…

Did you lose money on investments in Y-mAbs Therapeutics? If so, please visit Y-mAbs Therapeutics, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or to discuss your rights. NEW YORK, Jan 22, 2023…

SAN DIEGO, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB). The class action is on…

NEW YORK, Aug 17, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of TG Therapeutics, Inc.. Shareholders who purchased shares of TGTX during the class period listed are encouraged to contact the firm…

Investors with Losses of $100,000 can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, July 25, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Spero Therapeutics, Inc. ("Spero" or the…

Investors can contact the law firm at no cost to learn more about recovering their lossesLOS ANGELES, June…

LEAD PLAINTIFF DEADLINE IS JULY 25, 2022 NEW YORK, June 9, 2022 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a federal securities class action lawsuit has been filed against Spero Therapeutics, Inc.…

NEW YORK--(BUSINESS WIRE)--Bragar Eagel & Squire, PC, a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Spero Therapeutics, Inc. (“Spero” or the “Company”)…